Outcomes Management Conference: Quality of Cancer Care

这次为期1.5天的会议“癌症护理的质量：从证据到行动”是第三次由埃文斯顿西北医疗保健/西北大学赞助的结果管理会议。会议将于2003年9月17日至18日举行。会议的目标是向与会者提供如何识别和衡量高质量癌症护理的最新证据，以及如何将这些证据整合到实践中的信息和方法。这将通过讲座、互动讨论、小组讨论和同行评议的海报演示相结合的方式实现。整个会议将强调结果管理原则的使用，广义上定义为在应用医疗环境中使用临床、质量和成本数据来改变实践和/或展示价值。医疗保健研究和质量机构(AHRQ)主任、医学博士卡罗琳·克兰西将作开幕主旨演讲。克兰西博士将广泛概述成果研究和成果管理面临的挑战和机遇，为后续的具体讲座和讨论奠定基础。杰斐逊医学院卫生政策教授雷蒙德·C博士和多丽丝·N·格兰顿博士、医学博士、工商管理硕士戴维·纳什将在闭幕式上发表主旨演讲。纳什博士将从他设计成功成果管理的丰富经验出发，反思会议的目标和目的，特别是关于乳腺癌诊断和治疗的报告。会议将包括三个相互关联的会议：建立支持肿瘤学成果管理的证据基础；行动中的肿瘤学成果管理；以及关于乳腺癌的特别研讨会。第一个会议将集中在目前高质量癌症的证据基础上。来自主要组织的代表将重点介绍目前在国家、地区或地方各级开展的与癌症相关的护理质量和/或绩效改进倡议。小组讨论将展示政府、提供者和患者对提供最佳癌症护理所涉及的挑战和问题的看法。在第二次会议中，演讲者将描述肿瘤学方面的成果研究和绩效改进项目，这些项目说明了目前关于高质量癌症护理的知识的成功实施。同行评议的海报会议将展示更多的研究成果。我们的总结会议将包括介绍乳腺癌筛查/检测和治疗方面的质量和业绩改进。将制作会议记录以供分发，并将提交会议摘要供同行评议出版。预计将有大约200-250人(医疗保健提供者、研究人员和管理人员)参加。

This 1.5 day conference, "The Quality of Cancer Care: From Evidence to Action," is the third Evanston Northwestern Healthcare/ Northwestern University-sponsored conference on outcomes management. The conference will be held on September 17th-18th, 2003. The conference goal is to provide participants with the latest evidence on how to identify and measure quality cancer care along with information and methods on how to integrate that evidence into practice. This will be accomplished via a combination of lectures, interactive discussions, panel discussions, and a peer-reviewed poster presentation. Throughout, the conference will emphasize the use of outcomes management principles, broadly defined as the use of clinical, quality, and cost data in applied medical settings to change practice and/or demonstrate value. An opening keynote address will be given by Carolyn Clancy, MD, Director, Agency for Healthcare Research and Quality (AHRQ). Dr. Clancy will provide a broad overview of the challenges and opportunities facing outcomes research and outcomes management, setting the stage for specific lectures and discussion to follow. David Nash, MD, MBA, the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy at Jefferson Medical College, will give our closing keynote address. Speaking from his vast experience engineering successful outcomes management, Dr. Nash will reflect on the conference goals and objectives, specifically addressing the presentations on diagnosis and treatment of breast cancer. The conference will include three inter-related sessions: Building the Evidence Base to Support Outcomes Management in Oncology; Oncology Outcomes Management in Action; and a Special Symposium on Breast Cancer. The first session will focus on the current evidence base for quality cancer. Representatives from key organizations will highlight current cancer-related quality of care and/or performance improvement initiatives occurring at national, regional, or local levels. A panel discussion will present government, provider and patient perspectives on the challenges and issues involved in providing optimal cancer care. Presenters in the second session will describe outcomes research and performance improvement projects in oncology that illustrate successful implementation of current knowledge about quality cancer care. A peer-reviewed poster session will present additional research findings. Our concluding session will include presentations on quality and performance improvement in breast cancer screening/detection and treatment. Conference proceedings will be made for distribution, and a conference summary will be submitted for peer-reviewed publication. Approximately 200-250 people (health care providers, researchers, and administrators) are expected to attend.